• Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • Postpartum hemorrhage is the major killer of women in the developing world (one woman every four minutes dies this way). One of the key issues is the speed with which an anemic woman can lose her life if she is not provided life-saving care. Often women are lost in transit to a facility that could have provided the care. But what if you could ‘buy time’—stabilizing the woman until she reaches a higher level facility. This is the idea behind the NASG, a device that is a potential game changer for women’s survival. The NASG, also called the non-pneumatic anti-shock garment, is a medical device that externally wraps around a woman experiencing hemorrhage and ‘buys her time’--time to get to a higher level health facility with life-saving drugs and blood transfusion. Two key clinical studies of the LifeWrap device came out in late 2009—one from Nigeria and one from Egypt. Though much more could be written (and will be), to sum up, maternal mortality and morbidity was lower with the use of the NASG. The authors report that in both studies “the measured blood loss was significantly lower for women treated with the NASG: 78% lower in Nigeria and 50% lower in Egypt.” The study also found that uterine atony (failure of the uterus to contract)—and a major cause of postpartum hemorrhage—was the cause of hemorrhage in only 30% of the cases studied. The more that is understood about the reasons for postpartum hemorrhage the better.

    Leave a comment

    Comments will be approved before showing up.


    Also in The Maternova Blog

    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)
    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)

    May 25, 2026 1 min read

    High quality ISO 13485 and CE-marked Non-pneumatic anti shock garments (NASG) produced by Maternova for use by midwives and obstetricians all over the world to save lives threatened by postpartum hemorrhage.  Our NASGS adhere to the highest standards and are trusted by hundreds of clinicians. 

    Read More
    A $.03 pill that could prevent maternal deaths; Part 5
    A $.03 pill that could prevent maternal deaths; Part 5

    May 25, 2026 2 min read

    Read More
    A $.03 pill that could save maternal lives: low dose aspirin.... Part 3
    A $.03 pill that could save maternal lives: low dose aspirin.... Part 3

    May 25, 2026 2 min read

    A 2025 study at a Federally Qualified Health Center (FQHC) serving a socially vulnerable population proved that with implementation of a universal low dose aspirin protocol, adherence jumped from 8.7% to 75%.

    Read More